Mr. Adam Ho reports

ARCPOINT PROVIDES UPDATE ON MANAGEMENT CEASE TRADE ORDER APPLICATION AND DELAY IN FILING ANNUAL FINANCIAL STATEMENTS

Arcpoint Inc. has provided an update further to the news release dated July 15, 2026, regarding its application for a management cease trade order and the anticipated delay in filing its annual financial statements, accompanying management's discussion and analysis, and related chief executive officer and chief financial officer certificates for the year ended March 31, 2026, which are required to be filed on or before July 29, 2026.

As disclosed in the MCTO application announcement, the company had applied to the B.C. Securities Commission, as its principal regulator, for a management cease trade order under National Policy 12-203 (Management Cease Trade Orders). The company has been advised by the BCSC that its application for an MCTO has been declined. In declining the application, the BCSC advised that, based on the information provided, it does not consider the company to have the necessary financial resources in place to remedy its default as required under Section 6(c) of NP 12-203. The company has continued its efforts to secure the financial resources necessary to address the BCSC's concerns but has not yet been able to do so.

The BCSC has further advised the company that a failure-to-file cease trade order will be issued against the company if the annual filings are not filed by the annual filing deadline.

Unlike an MCTO, which would have restricted trading only by certain management and insiders of the company, an FFCTO, if issued, would generally prohibit all trading in the company's securities by any person, including trades made through the TSX Venture Exchange or otherwise, for so long as the FFCTO remains in effect. The FFCTO would remain in effect until the audited annual filings and any other related documents have been filed and the FFCTO has been revoked by the BCSC. The terms of any FFCTO, including any exceptions, will be as determined by the BCSC.

As previously disclosed, the delay in completing the annual filings results from the company's lack of available funds to pay its auditor and the accounting personnel responsible for completing the audit and the annual filings. The company has been working to secure the financial resources necessary to complete the audit and file the annual filings. As of the date of this news release, the company has not secured those resources to the BCSC's satisfaction, and the company will not be in a position to file the annual filings by the annual filing deadline, and, accordingly, the company expects that an FFCTO is likely to be issued.

The company continues to work toward filing the annual filings as soon as possible and will issue a further news release announcing a revised expected filing date once it is in a position to do so. The company intends to continue to provide updates by way of news release as required under applicable Canadian securities laws.

The company is not subject to any insolvency proceedings. If the company provides any information to any of its creditors during the period in which it is in default of filing the annual filings, the company confirms that it will also file material change reports on the company's profile on SEDAR+ containing such information.

About Arcpoint Inc.

Arcpoint is a health care technology company that owns and develops MAPL, a multitenant software platform for clinical lab ordering, scheduling and results delivery used by laboratories, collection sites and other health care service providers in the United States. Arcpoint's Class A subordinate voting shares trade on the TSX Venture Exchange under the symbol ARC.

We seek Safe Harbor.